BATS BZX Real-Time Price
As of 2:39pm ET
| -0.15 / -0.84%|
The 8 analysts offering 12-month price forecasts for Halozyme Therapeutics Inc have a median target of 20.00, with a high estimate of 26.00 and a low estimate of 6.00. The median estimate represents a +13.19% increase from the last price of 17.67.
The current consensus among 8 polled investment analysts is to Buy stock in Halozyme Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.